| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 28 |
| 1 | OMALIZUMAB | 26 |
| 2 | METFORMIN | 23 |
| 3 | METFORMIN ER 500 MG | 23 |
| 4 | METFORMIN ER 750 MG | 23 |
| 5 | ALBUTEROL SULFATE | 22 |
| 6 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 22 |
| 7 | ASPIRIN | 21 |
| 8 | ASPIRIN 325 MG | 21 |
| 9 | ASPIRIN 81 MG | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCOPYRROLATE | 8 | 0.0014 |
| 1 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 22 | 0.0006 |
| 2 | CICLESONIDE | 6 | 0.0004 |
| 3 | IPRATROPIUM BROMIDE | 15 | 0.0004 |
| 4 | NEPAFENAC | 1 | 0.0003 |
| 5 | FLUOROMETHOLONE | 1 | 0.0003 |
| 6 | OMALIZUMAB | 26 | 0.0003 |
| 7 | MEPOLIZUMAB | 14 | 0.0003 |
| 8 | BRINZOLAMIDE/BRIMONIDINE TARTRATE | 1 | 0.0002 |
| 9 | GLIPIZIDE | 14 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 35 |
| 1 | Anti-IgE [EPC] | 26 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 21 |
| 4 | Interleukin-5 Antagonist [EPC] | 14 |
| 5 | Sulfonylurea [EPC] | 14 |
| 6 | Loop Diuretic [EPC] | 10 |
| 7 | Proton Pump Inhibitor [EPC] | 10 |
| 8 | Leukotriene Receptor Antagonist [EPC] | 8 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 14 | 0.0203 |
| 1 | Anti-IgE [EPC] | 26 | 0.0003 |
| 2 | Leukotriene Receptor Antagonist [EPC] | 8 | 0.0003 |
| 3 | Sulfonylurea [EPC] | 14 | 0.0001 |
| 4 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 5 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Pyridone [EPC] | 2 | 0.0000 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 21 | 0.0000 |
| 8 | Corticosteroid [EPC] | 35 | 0.0000 |
| 9 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |